UFP Technologies Inc
NASDAQ:UFPT
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
155.66
358.42
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
UFP Technologies Inc
Total Equity
UFP Technologies Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
UFP Technologies Inc
NASDAQ:UFPT
|
Total Equity
$329.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
||
Haemonetics Corp
NYSE:HAE
|
Total Equity
$878.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
||
ICU Medical Inc
NASDAQ:ICUI
|
Total Equity
$2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
||
Align Technology Inc
NASDAQ:ALGN
|
Total Equity
$3.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
25%
|
CAGR 10-Years
18%
|
||
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Equity
$1.2B
|
CAGR 3-Years
33%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
||
Merit Medical Systems Inc
NASDAQ:MMSI
|
Total Equity
$1.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
UFP Technologies Inc
Glance View
UFP Technologies, Inc. engages in designing and custom manufacturing of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics primarily for the medical market. The company is headquartered in Newburyport, Massachusetts and currently employs 1,828 full-time employees. The firm's single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods and orthopedic implant packaging. The firm also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets. The applications of its products include military uniform and gear components, automotive interior trim, athletic padding, environmentally friendly protective packaging, air filtration, abrasive nail files, and protective cases and inserts. Its wholly owned subsidiaries include Moulded Fibre Technology, Inc., Simco Industries, Inc., Dielectrics, Inc., Contech Medical, Inc. and UFP Realty LLC.
See Also
What is UFP Technologies Inc's Total Equity?
Total Equity
329.1m
USD
Based on the financial report for Sep 30, 2024, UFP Technologies Inc's Total Equity amounts to 329.1m USD.
What is UFP Technologies Inc's Total Equity growth rate?
Total Equity CAGR 10Y
13%
Over the last year, the Total Equity growth was 21%. The average annual Total Equity growth rates for UFP Technologies Inc have been 20% over the past three years , 16% over the past five years , and 13% over the past ten years .